Emerging Nutrition Science on Fatty Acids and Cardiovascular Disease: Nutritionists' Perspectives
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Recent dietary guidance for heart health recommends a reduction (by ∼50%) in saturated fatty acid (SFA) intake to reduce LDL cholesterol and to decrease risk of cardiovascular disease (CVD). The 2010 Dietary Guidelines for Americans recommends substituting unsaturated fat [both polyunsaturated and monounsaturated fatty acids (PUFAs and MUFAs, respectively)] for SFAs. There are many dietary options that can be implemented to replace SFAs, given the different sources of unsaturated fats in the food supply. Compelling evidence exists for the cardioprotective benefits of n-3 (ω-3) PUFAs, both marine- and plant-derived. In addition, the evidence of cardioprotective benefits of n-6 (ω-6) PUFAs is strong, whereas that for MUFAs is mixed, although there is emerging evidence of benefits. Quantitatively, lowering SFAs by 50% will require, in part, substituting food sources of n-6 and n-3 PUFAs and MUFAs for food sources of SFAs. The use of n-3 PUFAs as a replacement for SFAs will result in a shortfall in reaching the SFA goal because of the relatively low amounts that can be incorporated in the diet, even with very high n-3 PUFA substitution. SFAs also can be replaced with dietary carbohydrate and/or protein. Replacing SFAs with carbohydrate, specifically refined sources, however, has little impact on reducing CVD risk. There is evidence about the health benefits of dietary protein on CVD risk, which merits study. Dietary guidelines have advanced considerably with the "replacement of SFA with unsaturated fat message" instead of recommending decreasing SFAs alone. A key question that remains is what is the optimal mix of macronutrients to maximally reduce CVD risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1806491 · Cited by 1,008
Retracted2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 2×
“Clinical studies have shown that when MUFAs replace carbohydrate in the diet, TGs, VLDL cholesterol, C-reactive protein (CRP), and blood pressure decrease, whereas HDL cholesterol and apo A-I increase (3, 65, 66).”
BackgroundJensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735
Trans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · cited 1×
“Although consumption of trans fats from partially hydrogenated oils adversely affects CVD risk, trans-palmitoleate, derived mainly from naturally occurring dairy and other ruminant trans fats, has not been associated with higher CVD risk (77).”
BackgroundMente, A., de Koning, L., Shannon, H. S., & Anand, S. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.38 · Cited by 1,267
Mozaffarian, D., Micha, R., & Wallace, S. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000252 · Cited by 1,215 · cited 1×
“(5), replacing SFAs with PUFAs significantly decreased risk of CAD or associated mortality rates.”
BackgroundAppel, L. J., Sacks, F. M., Carey, V. J., Obarzanek, E., Swain, J. F., Miller, E. R., Conlin, P. R., Erlinger, T. P., Rosner, B. A., Laranjo, N. M., et al. (2005) · JAMA · doi:10.1001/jama.294.19.2455 · Cited by 1,170
Liu, S., Willett, W. C., Stampfer, M. J., Hu, F. B., Franz, M., Sampson, L., Hennekens, C. H., & Manson, J. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1455 · Cited by 1,166
Howard, B. V., Van Horn, L., Hsia, J., Manson, J. E., Stefanick, M. L., Wassertheil-Smoller, S., Kuller, L. H., LaCroix, A. Z., Langer, R. D., Lasser, N. L., et al. (2006) · JAMA · doi:10.1001/jama.295.6.655 · Cited by 1,091
Jakobsen, M. U., O’Reilly, E. J., Heitmann, B. L., Pereira, M. A., Bälter, K., Fraser, G. E., Goldbourt, U., Hallmans, G., Knekt, P., Liu, S., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27124 · Cited by 1,026 · cited 6×
“After publication of the AHA Science Advisory in 2009, a pooled analysis of 11 cohort studies from the United States and Europe in 344,696 subjects followed for 4–10 y reported that replacing 5% of energy from SFAs with PUFAs was associated with a decreased risk of coronary events by 13% and coronary deaths by 26% (21…”
BackgroundMethodInfluentialn–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318277d6a0 · Cited by 845
Harris, W. S., Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, L. L., Appel, L. J., Engler, M. M., Engler, M. B., & Sacks, F. (2009) · Circulation · doi:10.1161/circulationaha.108.191627 · Cited by 794
Self-citationHu, F. B., Stampfer, M. J., Manson, J. E., Ascherio, A., Colditz, G. A., Speizer, F. E., Hennekens, C. H., & Willett, W. C. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.6.1001 · Cited by 661 · cited 1×
“(14), however, observed no increase in the risk of coronary heart disease (CAD) from short- to medium-chain SFA (4:0–10:0) consumption in the Nurses’ Health Study, whereas consumption of individual longerchain SFAs (12:0–18:0) did show an increase in the risk of CAD.”
BackgroundObarzanek, E., Sacks, F. M., Vollmer, W. M., Bray, G. A., Miller, E. R., Lin, P.-H., Karanja, N. M., Most-Windhauser, M. M., Moore, T. J., Swain, J. F., et al. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.1.80 · Cited by 598
Farvid, M. S., Ding, M., Pan, A., Sun, Q., Chiuve, S. E., Steffen, L. M., Willett, W. C., & Hu, F. B. (2014) · Circulation · doi:10.1161/circulationaha.114.010236 · Cited by 567
Micha, R., & Mozaffarian, D. (2010) · Lipids · doi:10.1007/s11745-010-3393-4 · Cited by 543
Ramsden, C. E., Zamora, D., Leelarthaepin, B., Majchrzak-Hong, S. F., Faurot, K. R., Suchindran, C. M., Ringel, A., Davis, J. M., & Hibbeln, J. R. (2013) · BMJ · doi:10.1136/bmj.e8707 · Cited by 523
Low-Carbohydrate-Diet Score and the Risk of Coronary Heart Disease in Women
Halton, T. L., Willett, W. C., Liu, S., Manson, J. E., Albert, C. M., Rexrode, K., & Hu, F. B. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055317 · Cited by 519
Astrup, A., Dyerberg, J., Elwood, P., Hermansen, K., Hu, F. B., Jakobsen, M. U., Kok, F. J., Krauss, R. M., Lecerf, J. M., LeGrand, P., et al. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004622 · Cited by 487
Dietary Prevention of Coronary Heart Disease: The Finnish Mental Hospital Study
TURPEINEN, O., J, M., PEKKARINEN, M., MIETTINEN, M., ELOSUO, R., & PAAVILAINEN, E. (1979) · International Journal of Epidemiology · doi:10.1093/ije/8.2.99 · Cited by 384
Chowdhury, R., Stevens, S., Gorman, D., Pan, A., Warnakula, S., Chowdhury, S., Ward, H., Johnson, L., Crowe, F., Hu, F. B., et al. (2012) · BMJ · doi:10.1136/bmj.e6698 · Cited by 379
Kwak (2012) · doi:10.1001/archinternmed.2012.262 · Cited by 368
Mozaffarian, D., Cao, H., King, I. B., Lemaitre, R. N., Song, X., Siscovick, D. S., & Hotamisligil, G. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-12-201012210-00005 · Cited by 363 · cited 2×
“In contrast, trans-palmitoleate (trans-16:1n–7) is an exogenous source of 16:1n–7 (76).”
Backgroundα-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis
Pan, A., Chen, M., Chowdhury, R., Wu, J. H., Sun, Q., Campos, H., Mozaffarian, D., & Hu, F. B. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.044040 · Cited by 329 · cited 2×
“(30) concluded that, in observational studies, higher ALA exposure”
BackgroundSkeaff, C. M., & Miller, J. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000229002 · Cited by 310 · cited 3×
“Meta-analyses of cohort studies, including those by Skeaff and Miller (19) and Jakobsen et al. (21), did not show benefits of MUFA-rich diets on relative CAD events and death.”
BackgroundMethodJakobsen, M. U., Dethlefsen, C., Joensen, A. M., Stegger, J., Tjønneland, A., Schmidt, E. B., & Overvad, K. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29099 · Cited by 209 · cited 1×
“(78) further showed that replacement of 5% of energy from SFAs by carbohydrate with a low glycemic index was associated with a nonsignificant reduction in CVD risk, whereas replacing SFAs by carbohydrate with a high glycemic index was associated with a 33% increased risk of MI (78).”
BackgroundOmega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis
Kotwal, S., Jun, M., Sullivan, D., Perkovic, V., & Neal, B. (2012) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.966168 · Cited by 201 · cited 1×
“(47) conducted a meta-analysis of 20 RCTs and reported that n–3 PUFA supplementation protected against cardiovascular death (RR: 0.”
BackgroundDavidson, M. H., Johnson, J., Rooney, M. W., Kyle, M. L., & Kling, D. F. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.01.002 · Cited by 191 · cited 1×
“This has been confirmed recently in the ECLIPSE (Epanova Compared to Lovaza in a Pharmacokinetic Single-dose Evaluation) I (60) and II (61) studies.”
Berglund, L., Lefevre, M., Ginsberg, H. N., Kris-Etherton, P. M., Elmer, P. J., Stewart, P. W., Ershow, A., Pearson, T. A., Dennis, B. H., Roheim, P. S., et al. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1611 · Cited by 172
Self-citationCasula, M., Soranna, D., Catapano, A. L., & Corrao, G. (2013) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(13)70005-9 · Cited by 152 · cited 1×
“(49), which included 11 RCTs providing $1 g marine-derived n–3 PUFA supplements/d for >1 y to patients with existing CVD, they observed significant risk reductions in cardiac death (232%), sudden death (233%), and MI (225%); no significant effect was reported for allcause mortality and stroke.”
BackgroundEgert, S., Kannenberg, F., Somoza, V., Erbersdobler, H. F., & Wahrburg, U. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.103861 · Cited by 152 · cited 1×
“In the third study (35), participants were randomly assigned to 1 of 3 intervention groups (ALA, EPA, or DHA) and asked to consume a specified margarine daily for 6 wk.”
BackgroundSchwingshackl, L., Strasser, B., & Hoffmann, G. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000334071 · Cited by 150 · cited 1×
“(69) in a meta-analysis that investigated the longterm ($6 mo) effects of high-MUFA (>12% MUFAs) vs.”
BackgroundDodin, S., Cunnane, S. C., Mâsse, B., Lemay, A., Jacques, H., Asselin, G., Tremblay-Mercier, J., Marc, I., Lamarche, B., Légaré, F., et al. (2008) · Nutrition · doi:10.1016/j.nut.2007.09.003 · Cited by 142
Dietary Prevention of Coronary Heart Disease in Women: The Finnish Mental Hospital Study
MIETTINEN, M., TURPEINEN, O., KARVONEN, M., PEKKARINEN, M., PAAVILAINEN, E., & ELOSUO, R. (1983) · International Journal of Epidemiology · doi:10.1093/ije/12.1.17 · Cited by 127
Jones, P. J., Senanayake, V. K., Pu, S., Jenkins, D. J., Connelly, P. W., Lamarche, B., Couture, P., Charest, A., Baril-Gravel, L., West, S. G., et al. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.081133 · Cited by 115 · cited 1×
“Similar results were recently reported in a large multicenter controlled feeding study for 2 high-MUFA oils and a high-PUFA oil blend on TC and LDL cholesterol (67).”
ResultSelf-citationOffman, E., Marenco, T., Ferber, S., Johnson, J., Kling, D., Curcio, D., & Davidson, M. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s50464 · Cited by 92
Fish Oil and Post-Operative Atrial Fibrillation
Mozaffarian, D., Wu, J. H. Y., de Oliveira Otto, M. C., Sandesara, C. M., Metcalf, R. G., Latini, R., Libby, P., Lombardi, F., O'Gara, P. T., Page, R. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.045 · Cited by 57 · cited 1×
“(57) reported in a meta-analysis of 8 short-term RCTs that fish oil use did not “appreciably” reduce postoperative AF.”
Background
Cited by
(2017) · doi:10.3390/healthcare5020029 · Cited by 410
Oppedisano, F., Macrì, R., Gliozzi, M., Musolino, V., Carresi, C., Maiuolo, J., Bosco, F., Nucera, S., Caterina Zito, M., Guarnieri, L., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8090306 · Cited by 323
AbuMweis, S., Jew, S., Tayyem, R., & Agraib, L. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12493 · Cited by 122
Ursoniu, S., Sahebkar, A., Serban, M.-C., Antal, D., Mikhailidis, D. P., Cicero, A., Athyros, V., Rizzo, M., Rysz, J., & Banach, M. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nuw063 · Cited by 48
Metadata
- Authors
- Kris-Etherton, P. M., & Fleming, J. A.
- Venue
- Advances in Nutrition
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 6
- Issue
- 3
- Pages
- 326S-337S
- ISSN
- 2156-5376 (ISSN-L)
- 2161-8313
- OpenAlex
- W2135909428
- Cited by
- 75
- References
- 41
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.